Zhai Xingjian, El Hiani Yassine
Department of Physiology and Biophysics, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Cancers (Basel). 2020 Dec 7;12(12):3669. doi: 10.3390/cancers12123669.
Despite extensive research, resistance to chemotherapy still poses a major obstacle in clinical oncology. An exciting strategy to circumvent chemoresistance involves the identification and subsequent disruption of cellular processes that are aberrantly altered in oncogenic states. Upon chemotherapeutic challenges, lysosomes are deemed to be essential mediators that enable cellular adaptation to stress conditions. Therefore, lysosomes potentially hold the key to disarming the fundamental mechanisms of chemoresistance. This review explores modes of action of classical chemotherapeutic agents, adaptive response of the lysosomes to cell stress, and presents physiological and pharmacological insights pertaining to drug compartmentalization, sequestration, and extracellular clearance through the lens of lysosomes.
尽管进行了广泛的研究,但化疗耐药性仍是临床肿瘤学中的一个主要障碍。一种令人兴奋的规避化疗耐药性的策略涉及识别并随后破坏在致癌状态下异常改变的细胞过程。在化疗挑战下,溶酶体被认为是使细胞适应应激条件的重要介质。因此,溶酶体可能是解除化疗耐药基本机制的关键。本综述探讨了经典化疗药物的作用方式、溶酶体对细胞应激的适应性反应,并从溶酶体的角度阐述了与药物区室化、隔离和细胞外清除相关的生理学和药理学见解。